Bio

David Anstaett is a first-chair trial and appellate lawyer who represents clients in intellectual property disputes and commercial litigation. David Anstaett primarily represents pharmaceutical and biotechnology clients in complex patent litigation. He has litigated patent infringement matters and licensing disputes in federal courts throughout the country and at the U.S. Court of Appeals for the Federal Circuit. David is a first-chair litigator who regularly leads successful trial teams in critical patent cases involving blockbuster drugs. David has also argued high-stakes pharmaceutical cases in inter partes review proceedings before the Patent Trial and Appeal Board. He counsels pharmaceutical companies on regulatory strategies and all aspects of the Hatch-Waxman Act. David’s practice also includes election and political law litigation and counseling.